Boya Bio-Pharmaceutical Group Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Public

  • Employees
  • 1,444

Employees

  • Stock Symbol
  • 300294

Stock Symbol

  • Investments
  • 4

  • Share Price
  • $4.52
  • (As of Friday Closing)

Boya Bio-Pharmaceutical Group General Information

Description

China Resources Boya Bio-pharmaceutical Group Co Ltd is a China-based medical industry group that integrates biochemical drugs, chemical drugs, and active pharmaceutical ingredients. It is engaged in the provision of medical and health products and services. The product categories of the company include blood products, biochemical drugs, chemical medicines and others. Some of the company's blood products include human albumin, rabies immunoglobulin, intravenous human immunoglobulin and human fibrinogen.

Contact Information

Formerly Known As
Jiangxi Boya Bio-Pharmaceutical Group
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
SHE
Corporate Office
  • No.333, Huiquan Road
  • High-tech Industrial Park
  • Fuzhou, Jiangxi 344000
  • China
+86 0794 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Boya Bio-Pharmaceutical Group Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.52 $4.44 $3.21 - $5.16 $2.28B 504M 4.94M $0.06

Boya Bio-Pharmaceutical Group Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 1,256,007 1,694,884 2,021,268 2,829,956
Revenue 320,885 374,844 409,635 410,484
EBITDA 40,990 59,562 89,598 80,764
Net Income 30,651 33,565 64,176 53,357
Total Assets 1,123,175 1,104,435 1,164,346 1,195,742
Total Debt 3,432 3,450 5,125 5,583
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Boya Bio-Pharmaceutical Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Boya Bio-Pharmaceutical Group‘s full profile, request access.

Request a free trial

Boya Bio-Pharmaceutical Group Executive Team (2)

Name Title Board Seat Contact Info
Fan Qin Chief Financial Officer, Secretary & Board Member
You’re viewing 1 of 2 executive team members. Get the full list »

Boya Bio-Pharmaceutical Group Board Members (4)

Name Representing Role Since
000 000 Boya Bio-Pharmaceutical Group Chief Financial Officer, Secretary & Board Member 000 0000
0000 00000 Boya Bio-Pharmaceutical Group Chairman 000 0000
00000 0000 Boya Bio-Pharmaceutical Group Board Member & Vice Chairman 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Boya Bio-Pharmaceutical Group Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Boya Bio-Pharmaceutical Group Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Boya Bio-Pharmaceutical Group‘s full profile, request access.

Request a free trial

Boya Bio-Pharmaceutical Group Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Hainan Tianhuang Pharmaceutical 14-Aug-2017 0000000000 Pharmaceuticals
Jiangxi Huiyinbi 01-Jan-2017 0000000000 Pharmaceuticals
Guizhou Tianan Pharmaceutical 26-Aug-2015 000000000 000.00 Pharmaceuticals 00 0000
Guizhou Tianan Pharmaceutical 30-Dec-2013 Merger/Acquisition Pharmaceuticals 00 0000
To view Boya Bio-Pharmaceutical Group’s complete investments and acquisitions history, request access »

Boya Bio-Pharmaceutical Group Subsidiaries (1)

Company Name Industry Location Founded
Guizhou Tianan Pharmaceutical Pharmaceuticals Guiyang, China 0000
To view Boya Bio-Pharmaceutical Group’s complete subsidiaries history, request access »

Boya Bio-Pharmaceutical Group ESG

Risk Overview

Risk Rating

Updated February, 04, 2023

35.14 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,191

Rank

00.0

Percentile

Pharmaceuticals

Industry

00 of 921

Rank

00.00

Percentile

Pharmaceuticals

Subindustry

00 of 452

Rank

00.00

Percentile

To view Boya Bio-Pharmaceutical Group’s complete esg history, request access »

Boya Bio-Pharmaceutical Group FAQs

  • When was Boya Bio-Pharmaceutical Group founded?

    Boya Bio-Pharmaceutical Group was founded in 1993.

  • Where is Boya Bio-Pharmaceutical Group headquartered?

    Boya Bio-Pharmaceutical Group is headquartered in Fuzhou, China.

  • What is the size of Boya Bio-Pharmaceutical Group?

    Boya Bio-Pharmaceutical Group has 1,444 total employees.

  • What industry is Boya Bio-Pharmaceutical Group in?

    Boya Bio-Pharmaceutical Group’s primary industry is Biotechnology.

  • Is Boya Bio-Pharmaceutical Group a private or public company?

    Boya Bio-Pharmaceutical Group is a Public company.

  • What is Boya Bio-Pharmaceutical Group’s stock symbol?

    The ticker symbol for Boya Bio-Pharmaceutical Group is 300294.

  • What is the current stock price of Boya Bio-Pharmaceutical Group?

    As of 21-Jun-2024 the stock price of Boya Bio-Pharmaceutical Group is $4.52.

  • What is the current market cap of Boya Bio-Pharmaceutical Group?

    The current market capitalization of Boya Bio-Pharmaceutical Group is $2.28B.

  • What is Boya Bio-Pharmaceutical Group’s current revenue?

    The trailing twelve month revenue for Boya Bio-Pharmaceutical Group is $321M.

  • What is Boya Bio-Pharmaceutical Group’s annual earnings per share (EPS)?

    Boya Bio-Pharmaceutical Group’s EPS for 12 months was $0.06.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »